Filing Details

Accession Number:
0001179110-17-015385
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-12-14 18:01:01
Reporting Period:
2017-12-14
Accepted Time:
2017-12-14 18:01:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1620564 Sive Gesua Daniel Salvadori 100 Abbott Park Road
Abbott Park IL 60064-6400
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Acquisiton 2017-12-14 28,319 $47.00 102,117 No 4 M Direct
Common Shares Without Par Value Disposition 2017-12-14 9,839 $54.90 92,278 No 4 S Direct
Common Shares Without Par Value Disposition 2017-12-14 1,483 $54.91 90,795 No 4 S Direct
Common Shares Without Par Value Disposition 2017-12-14 200 $54.91 90,595 No 4 S Direct
Common Shares Without Par Value Disposition 2017-12-14 200 $54.92 90,395 No 4 S Direct
Common Shares Without Par Value Disposition 2017-12-14 1,900 $54.92 88,495 No 4 S Direct
Common Shares Without Par Value Disposition 2017-12-14 100 $54.92 88,395 No 4 S Direct
Common Shares Without Par Value Disposition 2017-12-14 6,897 $54.93 81,498 No 4 S Direct
Common Shares Without Par Value Disposition 2017-12-14 7,700 $54.94 73,798 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Option (right to buy) Disposition 2017-12-14 28,319 $0.00 28,319 $47.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
42,479 2017-02-20 2025-02-19 No 4 M Direct
Footnotes
  1. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.